Alloanti‐D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling
Transfusion · 2025
DOI: 10.1111/trf.18369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Carolina Trucco Boggione und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Bioquímicas y Farmacéuticas, Laboratorio de Inmunohematología e Inmunogenética, IDICER - CONICET, Universidad Nacional de Rosari…. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Genetic Counseling, Isoantibodies, Rh-Hr Blood-Group System. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Agencia Nacional de Promocion Científica y Tecnológica, Universidad Nacional de Rosario.
Abstract (Originalsprache)
Background
While some partial D patients are not detected in routine D typing due to strong positive reactions with the commercially available anti‐D reagents used, clinically significant alloanti‐D against the absent epitopes can be produced following immunization with D‐positive (D+) erythrocytes. This study aimed to characterize the allelic variant underlying the D+ phenotype in an alloimmunized, pregnant woman (anti‐D titer: 64) and to provide genetic counseling to her close family members. Materials and Methods The proband and five family members were investigated in the study. Standard hemagglutination techniques were used in phenotyping and titration studies. A quantitative multiplex PCR of short fluorescent fragments (QMPSF) strategy was performed for RH genotyping.
Results
Our investigation revealed that the proband genotype was RHD*14.02 / RHD*01N.01 responsible for a partial D phenotype, that is, DBT. QMPSF analysis showed that the father and one of her brothers were heterozygous for RHD*14.02 / RHD*01 . The newborn presented with signs and symptoms of hemolytic disease of the fetus and newborn (HDFN), requiring medical intervention.
Discussion
The RHD variant identified in the maternal sample was responsible for a partial D phenotype. This case highlights the limitations of routine serologic typing for the D antigen, which misidentified a partial D phenotype as D+, preventing the patient from receiving appropriate prophylactic RhIg treatment. Interestingly, the QMPSF‐based strategy resulted in a simple, reliable, and effective method for a relevant allele characterization in all family members. Noteworthy, genetic counseling was provided to the proband's brother carrying the RHD*14.02 variant at the heterozygous state with an RHD*01 allele.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias Bioquímicas y Farmacéuticas, Laboratorio de Inmunohematología e Inmunogenética, IDICER - CONICET, Universidad Nacional de Rosario, Rosario, Argentina.
- Etablissement Français du Sang (EFS)-Bretagne, Brest; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Bre…
ORCID-Profile: Yann Fichou
Förderung
- Agencia Nacional de Promocion Científica y Tecnológica
- Universidad Nacional de Rosario
Zitieren
APA
Trucco Boggione, C., Bénech, C., Pigozzi, M. J., Orlandi, M. F., Brajovich, M. L., Fichou, Y., & Cotorruelo, C. (2025). Alloanti‐D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling. Transfusion. https://doi.org/10.1111/trf.18369
Vancouver
Trucco Boggione C, Bénech C, Pigozzi MJ, Orlandi MF, Brajovich ML, Fichou Y, et al. Alloanti‐D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling. Transfusion. 2025. doi:10.1111/trf.18369
BibTeX
@article{TruccoBoggione2025,
author = {Trucco Boggione, Carolina and Bénech, Caroline and Pigozzi, María José and Orlandi, María Florencia and Brajovich, Melina Luján and Fichou, Yann and Cotorruelo, Carlos},
title = {Alloanti‐D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18369}
}
EUVIMED